In order to characterize the effects of oncolytic adenovirus arming decorin (OAV-DEC) on immune response in the tumor microenvironment, we also evaluated its use in an immunocompetent mouse model because human decorin is cross-reactive for mouse cells. The gene discussed is DCN; the disease is neoplasm.